Politecnico is at the top of the world rankings of universities also thanks to the frontier scientific research it carries out in its laboratories. The protagonists of this Italian record are the approximately 3,500 scientists and researchers of Politecnico. Among the hottest topics are obviously those related to the systemic transformation towards climate neutrality; and then, the world of digital, space exploration, life sciences, the movements embraced by the New European Bauhaus, the new frontiers in the study of matter... In particular, young researchers inject new life into the research system and grow innovative scientific strands. Politecnico invests in activities aimed precisely at encouraging young scientists of excellence to join in. Among many, this year we welcome twelve new young researchers who are among the best of their generation. They are here at Politecnico di Milano thanks to the Marie Skłodowska-Curie Actions (MSCA) fellowship programme. Let us introduce them... in alphabetical order.
FEDERICA SEBASTIANI studies the relation between the structure and function of biocolloids and biomimetic systems. In recent years, she has been working on drug delivery, a process that enables medicines to reach areas of the body affected by a disease. "The formulation of nanocarriers (i.e., nanometric particles that carry drugs) has attracted increasing attention in recent decades. In particular, the possibility of combining therapeutic and imaging capabilities in a single nanoplatform (theranostics) has been widely explored to advance therapeutic approaches and promote the transition from conventional medicine to personalised medicine”. Sebastiani will study lipid nanocarriers for gene delivery. drug delivery, il processo che consente alle medicine di raggiungere zone del corpo colpite da patologie. “La formulazione di nanocarrier (cioè particelle nanometriche che trasportano i farmaci) ha attirato una crescente attenzione negli ultimi decenni. In particolare, la possibilità di combinare funzionalità terapeutiche e di imaging in un’unica nanopiattaforma (teranostica) è stata ampiamente esplorata per far progredire gli approcci terapeutici e promuovere la transizione dalla medicina convenzionale alla medicina personalizzata”. Sebastiani studierà nanocarrier lipidici per la consegna genica.